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Abstract 
 
Objective: This article discusses neuropathic foot pain with particular reference to complex regional pain syndrome. It provides 
recommendations for the clinical evaluation of complex regional pain syndrome and highlights the value of spinal cord stimulation in its 
management. The aim is to review neuropathic foot pain in complex regional pain syndrome and outline its management using spinal cord 
stimulation. It is important for Podiatrists managing such patients to have an understanding of this treatment modality. 
Methods: A narrative literature review was undertaken using English language medical databases combining search strategies for complex 
regional pain syndrome and spinal cord stimulation. 
Results: Spinal cord stimulation improves the subjective symptoms of the neuropathic foot pain of complex regional pain syndrome, enables 
objective functional improvement and reduces analgesic consumption. 
Conclusion: Recent technical developments in spinal cord stimulation have led to improved stimulation patterns adapted to the patients’ 
needs. Careful preoperative diagnosis, robust patient selection and frequent follow-up are vital for the success of this method. 
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Resumen 
 
Objetivos: Este artículo describe el dolor neuropático de los pies con especial referencia al síndrome de dolor regional complejo. Proporciona 
recomendaciones para la evaluación clínica del síndrome de dolor regional complejo y pone de relieve el valor de la estimulación de la 
médula espinal en su gestión. El objetivo es revisar dolor en el pie neuropático en el síndrome de dolor regional complejo y resumen de su 
gestión mediante la estimulación de la médula espinal. 
Material y métodos: Una revisión de la literatura narrativa se llevó a cabo utilizando bases de datos médicas de idioma Inglés la combinación 
de estrategias de búsqueda para el síndrome de dolor regional complejo y estimulación de la médula espinal. 
Resultados: Estimulación de la médula espinal mejora los síntomas subjetivos del dolor neuropático pies del síndrome de dolor regional 
complejo, permite la mejora funcional objetivo y reduce el consumo de analgésicos.  
Conclusión: Los avances técnicos recientes en la estimulación de la médula espinal han dado lugar a patrones de estimulación mejoradas 
adaptaciones a las necesidades del paciente. diagnóstico preoperatorio cuidadosa, la selección de pacientes robusto y seguimiento 
frecuente son vitales para el éxito de este método. Es importante que los podólogos gestión de estos pacientes a tener una comprensión 
de esta modalidad de tratamiento. 
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 Introduction  
 
Neuropathic pain constitutes a major portion of 
chronic pain and is an important, prevalent, and 
multifaceted problem. It has several components - 
sensory, autonomic, motor and affective 
(emotional) (1); each dimension occurring in 
isolation or in varying combinations (1). This 
disorder arises from damage, or pathological 
change, in the peripheral or central nervous system 
(2). It is usually a chronic condition and can be 
difficult to treat because conventional analgesics 
may not provide effective pain relief. Neuropathic 
pain syndromes are multidimensional, with 
psychological and functional issues (3) and 
numerous causes exist which can affect the lower 
limb (Table 1). Overall the condition is a large cost 
burden on healthcare services and is frequently 
associated with considerably greater impairment 
of quality of life compared to other kinds of 
chronic pain (3). The article aims to review 
neuropathic foot pain in complex regional pain 
syndrome (CRPS) and outline its management 
using spinal cord stimulation (SCS). 
 
Definition of neuropathic pain  
 
In contrast to inflammatory or nociceptive pain 
(caused by actual tissue damage), neuropathic 
pain arises as a direct consequence of a lesion or 
disease process affecting the somatosensory 
system (4).   
 
Peripheral and /or central nervous system can be 
affected (Table 1). Accordingly this can be 
peripheral or central neuropathic pain (depending 
on the site of lesion/dysfunction). As such, it 
represents a varying set of symptoms rather than a 
single entity (2). Somatosensory system damage 
can provoke a range of responses; an absence of 
sensation and pain is probably a more common 
response than new onset of pain. Sensitization of 
peripheral nerves with ectopic or spontaneous 
activity and hyper excitability in the modulatory 
pathways of the central nervous system are 
proposed mechanisms (5-7).  
 
 
 
 
Causes of neuropathic pain  
 
No universally accepted classification for 
neuropathic pain exists, however overlapping of 
several different disease processes may be 
responsible. Four broad classes of diseases are 
recognized based on aetiology and anatomy (5):  
focal and multifocal lesions of the peripheral 
nervous system, generalised polyneuropathies of 
peripheral nervous system, lesions in the central 
nervous system and complex neuropathic 
disorders (2) (Table 1).  
 
Table 1: Lower limb neuropathic pain syndromes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Prevalence of neuropathic pain 
 
Estimates of neuropathic pain associated with 
specific aetiologies have been described (2). 
Researchers have reported age standardized 
incidence rates of 26.7 for painful diabetic 
neuropathy, and 0.8 for phantom limb pain (8). 
The prevalence of neuropathic pain rises with age 
and severity of the underlying condition (9,10).  
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Overall prevalence of neuropathic pain in the 
general population is more difficult to quantify 
due to the numerous underlying causes and the 
lack of standardized measurement methods (2). 
Chronic pain is defined as pain, which has 
presented for greater than three months duration 
(7). Epidemiological surveys suggest that 6-8% 
of the general population report chronic pain with 
neuropathic characteristics (11, 12). Neuropathic 
back pain with radiating pain to the leg, and post-
traumatic neuropathic pain (accidental or 
surgical injury) are probably the most common 
causes (2). Sixty to eighty patients out of every 
1000 registered with a general practitioner will 
have symptoms of neuropathic pain; in half of 
these patients, pain will require medication and 
regular support (13).  
 
Clinical presentation of neuropathic pain 
 
The symptoms of neuropathic pain are often 
different than the traditional pain symptoms 
patients commonly experience. Painful symptoms 
often arise in an area of altered sensation 
(numbness or hyper excitability) and these are the 
hallmark of neuropathic pain. The cardinal 
symptoms of spontaneous pain and abnormal 
response to stimuli are common (2). The 
symptoms of neuropathic pain are summarized in 
Table 2. These are in contrast to nociceptive pain 
symptoms, which are usually described as sharp, 
aching, and/or throbbing pain (14). The features of 
neuropathic pain may be evident within days of 
nerve damage or can take months to develop. 
Sometimes, a minor insult to an area previously 
injured that had healed without a problem can 
trigger onset of neuropathic pain (2). 
 
Table 2: Neuropathic pain symptoms 
 
Materials and Methods  
 
 
The following criteria were used to search the 
literature: 
 
1. English language human studies. 
 
2. A narrative review of literature on use of 
spinal cord stimulation in complex regional 
pain syndrome published between 1993 and 
2016. 
 
3. Electronic databases: MEDLINE, PubMed, 
BioMed Central, Cochrane library, CINAHL, 
Highwire, AMED, Ovid, EMBASE, Science 
direct, BMJ clinical evidence, Science 
citation index, The Lancet.com, Scirus.com, 
Index to thesis, Controlledtrials.com UK.  
 
4. Medical subject heading terms used alone or 
in combination: Neuropathic pain, foot, lower 
limb, spinal cord stimulation, complex 
regional pain syndrome. 
 
 
5. Search limited to: peer-reviewed journals, 
systematic reviews/ meta-analyses, 
Randomized Controlled Trials, cohort 
studies, case control studies.  
 
6. Systematic reviews specific to CRPS and 
SCS were accessed to ensure high quality data 
and limit bias. 
 
7. Research papers were chosen based upon 
evaluation of neuropathic lower limb pain, 
complex regional pain syndrome and spinal 
cord stimulation. 
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Results  
 
Different methodological approaches were used 
to examine CRPS. Few included appropriate 
controls and sufficient cohort size to enable 
suitable statistical analysis with appropriate 
power calculation (15, 16). This made 
comparison and interpretation of CRPS studies 
difficult. Varied standardized criteria were used 
to confirm CRPS diagnosis but not all were 
evidence-based (15, 17). This has led to over 
diagnosis and often excessive pharmacotherapy 
(17). Where conservative treatment proved 
unsuccessful in controlling pain symptoms SCS 
was considered. 
 
Studies concurred that SCS is an effective 
management of the neuropathic foot pain of 
CRPS (18-20). SCS has been found to improve 
subjective symptoms, enable objective 
functional improvement and reduce the level of 
analgesic consumption (21, 22). Furthermore 
recent technical developments in SCS have led to 
improved stimulation patterns adapted to 
individual patients’ needs (23). 
 
 
Discussion 
 
Complex regional pain síndrome 
 
CRPS is a term devised by the International 
Association for the Study of Pain [14]. It is referring 
to a variety of disorders characterized by 
spontaneous pain, which is disproportionate to the 
provoking event and accompanied by a multitude 
of autonomic and motor disturbances in variable 
combinations (14). As such it probably has a 
multimodal aetiology (14).  
 
 
 
 
 
 
 
 
 
 
CRPS is a debilitating and painful condition, 
predominately affecting distal limbs after trauma.  
Researchers have reported a 4:1 female to male 
ratio with a higher incidence rate in Caucasians 
(24). The average age of onset of 40 year-of-age 
has been reported (14). It is defined as a regional 
neuropathic pain disorder arising in the context of 
a fracture, soft tissue injury or surgical trauma (14, 
25), although in about 10% of cases no 
precipitating event can be identified (14,25,26).  
 
CRPS usually affects one limb, but in 7% of cases 
later spreads to involve additional limbs (27).  
 
The incidence of upper limb CRPS is twice as 
common as lower limb (28). The clinical 
phenotype of CRPS has been better defined over 
the last few decades: diagnostic criteria such as 
Budapest or Veldman capture these essential 
clinical features (29, 30,31) but no diagnostic tests 
are available (14). It is noted that, without limb 
signs, a diagnosis of CRPS according to the 
Budapest criteria can often not be made (26, 31).  
 
CRPS is primarily associated with sensory, motor, 
autonomic, skin and bone abnormalities (32). 
Clinical features of spontaneous pain, oedema, 
hyperalgesia, temperature or sudomotor changes, 
motor function abnormality, and autonomic 
changes (Table 3) are the hallmark of CRPS (34).   
 
The factors necessary to evaluate a patient with 
CRPS are summarized in Table 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eur J Pod 2017; 3 (1): 8-17 © 2017 Universidade da Coruña  
ISSNe: 2445-1835 
 
 
http://dx.doi.org/10.17979/ejpod. 2017.3.1.577                                                                                                                          EJPOD 
 
 
Table 3. Considerations when evaluating Complex Regional Pain 
Syndrome 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Footnote:  
The Budapest (22) or Veldman (33) criteria may be applied to help confirm CRPS diagnosis. 
 
 
CRPS is often misdiagnosed as it can mimic a 
large number of similar conditions; hence affected 
patients typically experience a delay in diagnosis 
and commencement of appropriate management. 
Most experts believe that CRPS is multifactorial 
in nature and pathophysiology (14, 28). These 
include inflammation, autoimmune responses, 
abnormal cytokine production, sympathetic 
sensory disorders, altered blood flow and central 
cortical reorganization (15). Due to the 
multifactorial pathophysiology, CRPS can differ 
in severity and duration between patients, and can 
even vary with time in the same patient (16). 
Incidence and prevalence studies of CRPS show 
that most cases are mild and individuals recover 
gradually with time. In severe cases, individuals 
may not recover and may suffer long-term 
disability (26, 17).  
 
 
 
 
CRPS is believed to be caused by damage to, or 
malfunction of, the peripheral and/or central 
nervous systems (28). Onset of symptoms can 
occur within one month of trauma or 
immobilization of the limb and the pain 
experienced is out of proportion in relation to the 
trauma (26). CRPS is characterized by prolonged 
(normally >6 months) or excessive pain and mild 
to dramatic changes in skin colour, temperature, 
and/or swelling in the affected area (35). 
 
Two forms of CRPS exist (CRPS-1 and CRPS-II), 
with the same symptoms and treatments. CRPS-II 
(previously called causalgia) is the term used for 
patients with confirmed nerve injuries (17).  
Individuals without confirmed nerve injuries are 
classified as having CRPS-I (previously called 
reflex sympathetic dystrophy). Some research has 
identified evidence of nerve injury in CRPS-I, so 
the validity of the two different forms is being 
investigated (35). 
 
Scant information is available regarding the types 
of patients who develop CRPS in the lower 
extremity (36, 37). A retrospective study 
examined 64 patients (predominantly white, 
middle-aged women) with lower extremity CRPS-
I (38). The most common precipitating injuries 
observed were blunt foot trauma (with or without 
fracture) or ankle sprain. The most common 
inciting surgical events were hallux valgus, tarsal 
tunnel release and heel surgery (38). In lower 
extremity CRPS the dominant cause is trauma 
(73%) with elective foot surgery accounting for 
the remaining cases (27%) (16). The most 
common type of trauma was fracture (45%) 
whereas neurectomy was the most common type 
of elective foot surgery. Research reveals middle-
age females with a history of anxiety or depression 
have a greater risk of developing CRPS after foot 
and ankle surgery (29). A recent study identified 
novel risk factors relating to deep-tissue ischaemia 
following surgical repair of peripheral fractures, 
thus providing new insights into one of the triggers 
of CRPS (39).  
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Findings about CRPS are conflicting. This may be 
due to the complexity of and difficulty in 
researching the condition. Different 
methodologies such as the variable use of 
standardized criteria to confirm diagnosis make 
comparison of study findings difficult to interpret. 
 
Management of CRPS 
 
Recent and significant advances across medical 
disciplines have improved the general 
understanding of CRPS (28). Current evidence 
indicates that CRPS is a disorder of multifactorial 
origin and of complex pathophysiology. Hence 
carefully selected multimodal management using 
a biopsychosocial approach is indicated.  
 
Pharmacological and non-pharmacological 
treatment is carefully tailored to individual needs 
depending on the stage and severity of the 
condition (28). Treatment of CRPS remains 
controversial and the literature reports various 
methods (Table 4), however, the goals are similar; 
pain relief, decrease in morbidity, and restoration 
of functional status (34). 
 
 
Table 4: Management of Complex Regional Pain Syndrome 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neuropathic pain is an inherently biopsychosocial 
problem with an important psychological 
component. It can potentially influence every 
human activity and experience and is therefore 
very personal in the way in which it is perceived. 
Since research and treatment activities are also 
patterns of human behaviour, pain is a challenging 
problem from a psychological point-of-view. 
Consequently its management model needs to be 
complex enough to meet the notions of health and 
behavior change.  
 
The dominant psychological approach to chronic 
pain is cognitive behavioural therapy [40], a 
psychotherapeutic approach combining cognitive 
and behaviour therapy.  It focuses on how a patient 
thinks about things going on in their life – their 
thoughts, images, beliefs and attitudes (cognitive 
processes) and how these impact on the way they 
behave and deal with emotional problems [40].  A 
number of psychosocial issues are known to 
influence the care of CRPS (Table 5). 
 
Table 5: Psychosocial issues influencing care of Complex Regional 
Pain Syndrome 
 
 
 
 
 
 
 
 
 
 
In cases of CRPS where conservative treatments are 
unsuccessful in controlling pain symptoms SCS 
may need to be considered. 
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The application of spinal cord stimulation  
 
Spinal cord stimulation is generally reserved for 
CRPS which is refractory to conventional 
conservative management. It is a relatively safe 
procedure and reversible with implant removal. 
The pain relieving effect of SCS as a treatment of 
neuropathic pain, pain due to peripheral ischemia 
and angina pectoris is well recognized (18-20, 41).  
 
Recent technical advancement of SCS enables 
stimulation patterns to be adjusted according to the 
patient’s needs, thus increasing stimulation 
efficiency. The neuromodulatory technique of 
SCS has evolved as a direct clinical application of 
the gate-control theory, the general 
conceptualization of which still provides the 
framework in explaining its mode of action (3). 
 
 According to the theory, the proposed gating 
mechanisms activated by SCS would imply that 
both acute and chronic pain of a nociceptive nature 
could be suppressed (3). This is an inconsistency 
because SCS is preferentially, or perhaps 
exclusively, effective for neuropathic pain 
management (3, 41).  
 
The National Institute for Clinical Excellence has 
shown SCS to be cost effective in the managing 
CRPS (42). A growing body of evidence supports 
the benefits of SCS in managing neuropathic pain 
(3, 21, 22, 43-45). Studies of SCS demonstrate 
greater efficacy in neuropathic as opposed to 
nociceptive pain syndromes; however, the 
neurobiology for this is poorly understood (3).  
 
Successful management with SCS depends on a 
robust multidisciplinary approach to patient 
selection and management (3). The psychological 
profile of patients chosen for SCS must be 
considered (3).  
 
The waiting time from development of chronic 
pain syndrome to initiation of SCS can influence 
treatment efficacy. SCS efficacy is inversely 
proportional to the time interval between 
development of chronic pain and time of SCS 
implantation (44).  
 
Explanation of spinal cord stimulation  
 
Stimulating electrodes are placed through a needle 
into the spine near the spinal cord and activated to 
provide a mapped paraesthesia in the painful area. 
In the case of lower limb pain, the usual electrode 
position is Thoracic10-12 vertebral level. A two-
step procedure is undertaken with a test phase 
before implantation of the impulse generator 
(IPG). Typically the electrode is placed 
temporarily for several days to assess whether 
stimulation will be helpful (stage 1).  
 
Efficacy measures include: subjective symptom 
improvement, objective reduced analgesic 
consumption, and objective improvement in 
function. If successful (>50% pain reduction), 
either a laminotomy is undertaken (stage 2) to 
insert a surgical paddle or the percutaneous trialed 
leads are internalized. The IPG is connected to the 
leads and implanted under the skin on the 
abdomen, buttock or side of the chest (Figure 1) 
(3). Once implanted, the stimulator can be turned 
on and off, and adjusted (programmed) using an 
external controller. Electrode polarity (anode, 
cathode), current amplitude, pulse width, and rate 
can be regulated to achieve optimum analgesia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic of implanted Spinal Cord Stimulation 
 (Raphael et al, 2009). With permission. 
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Re-programing of the IPG is often needed one or 
more times. The patient can determine over time 
which stimulation pattern (intermittent or 
continuous) is most suitable. The SCS creates 
paraesthesia over the area of pain and can give 
several hours of pain relief after cessation of the 
stimulation. Position-adaptive IPG devices now 
detect whether the patient is lying down or 
standing so there is no longer any need for the 
patient to adjust stimulation intensity after 
changing their position. 
 
Analgesic mechanisms 
 
A number of neurotransmitters change with SCS. 
The anti-nociceptive effects of SCS are due to 
modulation of gamma amino-butyric acid release 
in the dorsal horn, which may modulate pain by 
controlling the release of excitatory amino acids 
(asparte & glutamate) (3). A similar model lends 
support to the modulatory role of SCS upon 
adenosine in the dorsal horn. Other mediators 
through which some analgesic effects of SCS may 
act include serotonin and substance P (46). 
 
 
Indications for use 
 
Numerous indications exist for the use of SCS for 
neuropathic lower limb pain (Table 6.). Spinal 
cord stimulation is contraindicated in the presence 
of marked psychological difficulties (major 
depression, anxiety, personality disorder, 
psychosis or poor coping strategy), coagulation 
abnormalities (including anticoagulant therapy), 
demand pacemaker, implanted defibrillator, 
systemic/ local infection and immunosuppression 
(3, 23).  
 
 
 
 
 
 
 
 
 
 
 
Table 6. Lower limb indications of Spinal Cord Stimulation 
 
 
 
 
Limitations/ risk of bias 
 
The review was not without limitations. Papers 
were confined to English language only as 
translation services were unavailable. The 
literature was reviewed by one researcher (PB), 
although all authors were involved in appraising 
the overall findings and their relevance. 
 
Conclusions  
 
This paper outlines the value of using a SCS for 
managing the neuropathic foot pain of CRPS, 
where standard treatment modalities have failed to 
control symptoms. Spinal cord stimulation has 
been shown to be a clinically and cost-effective 
therapy in the management of patients with CRPS 
(20,47,48). Technical advancements of SCS have 
led to improved stimulation patterns adapted to the 
patients’ needs. Careful preoperative diagnosis, 
robust patient selection and frequent follow-up are 
vital for the success of this method.  
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